The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal

被引:26
作者
Hundt, W [1 ]
Zimmermann, U [1 ]
Pöttig, M [1 ]
Spring, K [1 ]
Holsboer, F [1 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
关键词
alcoholism; withdrawal; cortisol; ACTH; Dex/CRH test;
D O I
10.1111/j.1530-0277.2001.tb02268.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Chronic alcoholism is often accompanied by disturbances of the hypothalamic-pituitary-adrenal (PIPA) system. Patients with alcoholism frequently show nonsuppression in the dexamethasone (Dex) suppression test and also a blunted increase of adrenocorticotropin (ACTH) after injection of corticotropin-releasing hormone (hCRH). However, the underlying mechanisms have not been fully elucidated. The combined Dex/CRH test (pretreatment with 1.5 mg dexamethasone at 2300 hr, injection of 100 mug hCRH at 1500 hr the next day) has been established as a more sensitive tool to investigate HPA system regulation in depressed patients. Methods: We studied the effect of the combined Dex/CRH test in 19 alcoholic inpatients (9 male, 10 female) during and after withdrawal along with 19 healthy controls. Results: Compared to normal controls, patients showed a severely dysregulated HPA system during withdrawal, with significantly elevated cortisol and ACTH response to hCRH after pretreatment with dexamethasone. After completed withdrawal, cortisol levels after injection of hCRH were almost normalized while ACTH values were partially lower in patients, compared to controls. Conclusions: We conclude that the HPA system is severely disturbed during alcohol withdrawal, possibly reflecting an exaggerated release of hypothalamic corticotropin and vasopressin.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 34 条
[1]   DEXAMETHASONE SUPPRESSION TEST IN ALCOHOLISM [J].
ABOUSALEH, MT ;
MERRY, J ;
COPPEN, A .
ACTA PSYCHIATRICA SCANDINAVICA, 1984, 69 (02) :112-116
[2]   Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence [J].
Adinoff, B ;
Anton, R ;
Linnoila, M ;
Guidotti, A ;
Nemeroff, CB ;
Bissette, G .
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (03) :288-295
[3]  
ADINOFF B, 1990, ARCH GEN PSYCHIAT, V47, P325
[4]  
ADINOFF B, 1991, AM J PSYCHIAT, V148, P1023
[5]   CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT [J].
BALDWIN, HA ;
RASSNICK, S ;
RIVIER, J ;
KOOB, GF ;
BRITTON, KT .
PSYCHOPHARMACOLOGY, 1991, 103 (02) :227-232
[6]   Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies [J].
Cole, MA ;
Kim, PJ ;
Kalman, BA ;
Spencer, RL .
PSYCHONEUROENDOCRINOLOGY, 2000, 25 (02) :151-167
[7]   An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics [J].
Costa, A ;
Bono, G ;
Martignoni, E ;
Merlo, P ;
Sances, G ;
Nappi, G .
PSYCHONEUROENDOCRINOLOGY, 1996, 21 (03) :263-275
[8]   DIFFERENCES IN CORTICOSTERONE AND DEXAMETHASONE BINDING TO RAT-BRAIN AND PITUITARY [J].
DEKLOET, R ;
WALLACH, G ;
MCEWEN, BS .
ENDOCRINOLOGY, 1975, 96 (03) :598-609
[9]  
DELPORTO JA, 1985, BIOL PSYCHIAT, V20, P1156
[10]  
Feuerlein W, 1979, Curr Alcohol, V7, P137